-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HadBX2krVvgVAT51FX/q9O+iIzFxjCbHKbOUgZGgGmPKPwJLYCzJlo5fk9/9Qaaw
 acUhVuAK3EEocU3BI8r+mA==

<SEC-DOCUMENT>0000914317-08-002957.txt : 20081212
<SEC-HEADER>0000914317-08-002957.hdr.sgml : 20081212
<ACCEPTANCE-DATETIME>20081212125226
ACCESSION NUMBER:		0000914317-08-002957
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20081211
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20081212
DATE AS OF CHANGE:		20081212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BALCHEM CORP
		CENTRAL INDEX KEY:			0000009326
		STANDARD INDUSTRIAL CLASSIFICATION:	CHEMICALS & ALLIED PRODUCTS [2800]
		IRS NUMBER:				132578432
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13648
		FILM NUMBER:		081245776

	BUSINESS ADDRESS:	
		STREET 1:		P O BOX 600
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958
		BUSINESS PHONE:		8453265632

	MAIL ADDRESS:	
		STREET 1:		P O BOX 600
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k-96443_bcp.txt
<DESCRIPTION>8-K
<TEXT>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 Current Report


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of report (date of earliest event reported): December 11, 2008

                               Balchem Corporation
             (Exact name of registrant as specified in its charter)

Maryland                                    1-13648          13-257-8432
(State or other jurisdiction of    (Commission File Number)  (IRS Employer
incorporation)                                               Identification No.)

                       P.O. Box 600, New Hampton, NY 10958
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (845) 326-5600

      Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[_]   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

[_]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

[_]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

[_]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))

<PAGE>


ITEM 7.01 REGULATION FD DISCLOSURE.

On December 11, 2008, Balchem Corporation (the "Company") issued a press release
announcing a dividend declared by the Company's Board of Directors on December
10, 2008. A copy of the press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K.

Item 9.01  Financial Statements and Exhibits.

(c)  Exhibits

Exhibit 99.1       Press Release of Balchem Corporation dated December 11, 2008.



<PAGE>


                                    SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                               BALCHEM CORPORATION


                                               By:/s/ Dino A. Rossi
                                               ---------------------------------
                                               Dino A. Rossi, President &
                                               Chief Executive Officer

Dated: December 12, 2008


<PAGE>


                                  Exhibit Index


Exhibit Number     Description
- --------------     -----------


99.1               Press Release of Balchem Corporation dated December 11, 2008.



</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.txt
<DESCRIPTION>EX-99.1
<TEXT>
Exhibit 99.1




                              FOR IMMEDIATE RELEASE

                     Balchem Corporation Announces Dividend

New Hampton, New York. December 11, 2008. Balchem Corporation (NASDAQ: BCPC)
today announced that its Board of Directors has declared a dividend on its
shares of common stock equal to $0.11 per share, payable on January 20, 2009 to
holders of record on December 22, 2008. Dino A. Rossi, Balchem's Chairman, CEO
and President stated, "As in the past, and even in these difficult economic
conditions, we remain committed to rewarding our shareholders. Given our current
progress and financial status, we are pleased to announce this annual dividend,
consistent with the level of last year."

Segment Information

Balchem Corporation consists of three business segments: ARC Specialty Products;
Food, Pharma and Nutrition; and Animal Nutrition and Health. ARC Specialty
Products provides specialty-packaged chemicals for use in healthcare and other
industries. The Food, Pharma and Nutrition segment develops innovative micro
encapsulation, granulation and agglomeration solutions for a variety of
applications in the human food, pharmaceutical and nutrition marketplaces. The
Animal Nutrition and Health segment manufactures and supplies products,
including encapsulated ingredients, Keyshure(R) organic trace minerals and
animal grade choline to numerous animal health markets and certain derivative
products into industrial applications.

Forward Looking Statements

This release contains forward-looking statements, which reflect Balchem's
expectation or belief concerning future events that involve risks and
uncertainties. Balchem can give no assurance that the expectations reflected in
forward looking statements will prove correct and various factors could cause
results to differ materially from Balchem's expectations, including risks and
factors identified in Balchem's annual report on Form 10-K for the year ended
December 31, 2007. Forward-looking statements are qualified in their entirety by
the above cautionary statement. Balchem assumes no duty to update its outlook or
other forward-looking statements as of any future date.


Contact:   Frank Fitzpatrick, Chief Financial Officer
           Telephone:  845-326-5600
            e-mail:  ffitzpatrick@balchemcorp.com


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
